June 13, 2022
CHARLOTTE, N.C. – Overnight sleep electroencephalography (EEG) contains an abundance of brain wave data that could be mined to identify an individual’s risk for a host […]
June 10, 2022
Two rare mutations in the APOE gene ― APOE ε4 (R251G) and APOE ε3 (V236E) ― dramatically reduce the risk of developing Alzheimer’s disease (AD), results […]
June 10, 2022
Herpes zoster does not appear to increase dementia risk ― on the contrary, the viral infection may offer some protection, a large population-based study suggests. “We […]
June 10, 2022
The study covered in this summary was published on medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways Mild traumatic brain injury […]
June 10, 2022
Physicians and patients agree on the importance of sleep for health, yet few clinicians obtain a patient sleep history, and few patients discuss their sleep problems […]
June 10, 2022
NATIONAL HARBOR, Maryland — Ublituximab (TG Therapeutics, Inc), an investigational anti-CD20 monoclonal antibody infused once every 6 months, is effective for treating relapsing forms of multiple […]
June 9, 2022
NATIONAL HARBOR, Maryland — Evobrutinib, an investigational Bruton’s tyrosine kinase (BTK) inhibitor for relapsing multiple sclerosis (RMS), is relatively safe and effective over the long-term, new […]
June 9, 2022
A person’s ‘genetic’ height – the height they are predicted to reach independent of environmental influences – may be an underappreciated risk factor for a wide […]
June 9, 2022
NATIONAL HARBOR, MD — As multiple sclerosis (MS) therapies expand and therapeutic decision-making becomes more complex, new research shows that general neurologists fall far below MS […]